Thromboangiitis obliterans: Difference between revisions

(added clinical features, video)
 
(2 intermediate revisions by 2 users not shown)
Line 8: Line 8:
*Male
*Male
*Middle Eastern
*Middle Eastern
{{Primary Vasculitis DDX}}


==Clinical Features==
==Clinical Features==
Line 16: Line 18:
*In-step claudication
*In-step claudication
*Hand claudication
*Hand claudication
*Raynaud phenomenon
**Often bilateral and symmetrical  
**Often bilateral and symmetrical  
**May lead to ulceration
**May lead to ulceration
*Raynaud phenomenon
*Gangrene and autoamputation of digits in severe disease


==Differential Diagnosis==
==Differential Diagnosis==
Line 47: Line 50:
==References==
==References==
<references/>
<references/>
==Video==
{{#widget:YouTube|id=daB4UWA7RXk}}


[[Category:Vascular]]
[[Category:Vascular]]

Latest revision as of 22:45, 27 March 2024

Background

  • Also known as "Buerger's disease"
  • Idiopathic inflammatory occlusive disease of the hands and feet (exact pathogenesis unknown)

Risk factors

  • Tobacco use
    • Virtually all affected patients are smokers
  • Male
  • Middle Eastern

Vasculitis Syndrome Types

Clinical Features

Thromboangiitis obliterans of foot
PMC5024906 AJUM-14-18-g002.png
  • Red, tender nodules over peripheral arteries
    • May have diminished pulses
  • In-step claudication
  • Hand claudication
    • Often bilateral and symmetrical
    • May lead to ulceration
  • Raynaud phenomenon
  • Gangrene and autoamputation of digits in severe disease

Differential Diagnosis

Blue Digit

Evaluation

  • Clinical criteria for diagnosis (noninvasive testing not necessary)
    • History of smoking
    • Onset prior to <50 years old
    • Absence of atherosclerotic risk factors
    • Upper limb involvement
    • Infrapopliteal arterial occlusive lesions

Management

  • Abstinence from tobacco
  • Early symptoms with out threatened tissue loss: outpatient vascular
  • Advanced disease: intra-arterial or intravenous PGE1, ASA, Heparin, arterial reconstruction, sympathectomy

Disposition

  • Discharge with vascular follow-up if no evidence/threat of tissue loss
  • Otherwise admit

See Also

External Links

References